Iveric Bio Inc (NASDAQ:ISEE)
| 5.95 Delayed Data As of Apr 16 |  -0.22 / -3.57%Today’s Change | 3.51 Today|||52-Week Range 7.98 | -13.89% Year-to-Date |
Latest ISEE News | Press Releases
| New Strong Sell Stocks for April 6th Apr 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.17 |
| Today’s open | 6.25 |
| Day’s range | 5.93 - 6.29 |
| Volume | 425,343 |
| Average volume (3 months) | 704,867 |
| Market cap | $536.5M |
Data as of 3:59pm ET, 04/16/2021
Growth & Valuation
| Earnings growth (last year) | +18.24% |
| Earnings growth (this year) | +19.38% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.80 |
Competitors
| ---- | ||
| MRNSMarinus Pharmaceutic... | -0.25 | -1.74% |
| PRVBProvention Bio Inc | +0.03 | +0.37% |
| MIRMMirum Pharmaceutical... | +0.13 | +0.71% |
Data as of 3:59pm ET, 04/16/2021
Financials
| Next reporting date | May 12, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$84.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
